2022/05/26

A Clinical Doctor's Explanation of Health Tech in Asia (Series#4)

Aevice Health Develops Wearable Stethoscopes for Chronic Respiratory Disease Patients

Medical communication, Clinical Doctor

The Usefulness of “AeviceMD” and Challenges for Clinical Use

 

Not displayed properly, along with End Of Support Lifecycle of Internet Explorer.
A coin-sized wearable stethoscope, “AeviceMD”
Source: Aevice Health Pte Ltd

About Aevice Health
Aevice Health is a Singapore-based MedTech company from Nanyang Technological University. Adrian Ang, CEO and co-founder of Aevice Health has had asthma since childhood and has repeatedly been in and out of the hospital. This experience led him to establish a company to develop digital solutions to control chronic respiratory diseases such as asthma and chronic obstructive pulmonary disease (COPD). The product thus developed is “AeviceMD,” a smart wearable stethoscope for chronic respiratory disease patients to manage and monitor their symptoms at home. The company is a pre-series A company and has already raised US$3.2 million in funding and has partnerships with Toho Holdings, a Japanese listed company, and others.

Not displayed properly, along with End Of Support Lifecycle of Internet Explorer.
Product Development at Aevice Health
Source: Aevice Health Pte Ltd

About “AeviceMD”
“AeviceMD” is a coin-sized wearable stethoscope (approximately 3cm in diameter) that provides patients with chronic respiratory disease a way to manage their condition and to stay connected to their clinicians while at home. The device is worn on the right side of the chest while the patient is resting or sleeping and continuously records heart rate and respiratory rate. It also constantly monitors breathing and heart sounds and detects and records wheezing (abnormal breathing sounds that occur during attacks of chronic respiratory diseases such as asthma).

The transmitted and recorded data can be shared with clinicians, who can then learn more about the severity of the disease and the effectiveness of treatment. Therefore, it is believed that these data can lead to better treatment outcomes of chronic respiratory diseases. “AeviceMD” is currently undergoing clinical trials in Singapore and is pending approval from the U.S. Food and Drug Administration (FDA). The company is also actively considering bringing the device to Japan.

Not displayed properly, along with End Of Support Lifecycle of Internet Explorer.
Display of recorded data
Source: Aevice Health Pte Ltd

(Continue to the next)


The information contained in this article is compiled by the respective authors based on publicly available information. We assume no responsibility whatsoever for any damage or disadvantage caused by actions taken based on such information. Unauthorized reproduction of articles, photos, charts, etc. is prohibited.
Copyright © 2022 LSMIP office / CM Plus Corporation

A Series of Articles

About the Author

Related Articles

No information is found.

Digital Health
U.S. eHealth Journal

Vol. 75 (Issued at 2022/11/22)

ジャーナル77号のトピックは、Theranica(ニューロモジュレーションによる片頭痛治療)、TrialSpark(臨床試験被験者登録支援)、Rock Health(投資トレンド分析)、Ro(DTCテレヘルス) など

Most Popular

1

Mitsutoshi Yamada

2

The First Part: Tapping into the Challenges of Diabetes and Lifestyle Management, Health2Sync

Natsu Ono M.D.

3

LSMIP Editorial Office

4

Mitsutoshi Yamada

5

The first part: Apps and Wearable Devices in Sleep

Nanao Amano

Press Room

Placeholder